December 2, 2019
The global stem cell therapy market is expected to grow at a CAGR of 36.52 percent between 2017 and 2021....
October 7, 2019
The company received a notice of allowance for its US Patent Application called 'Method of Qualifying Cells.'
January 22, 2019
BrainStorm Cell Therapeutics (NASDAQ:BCLI), a leader in developing innovative autologous cellular therapies for debilitating neurodegenerative diseases, today announced that the...
January 18, 2019
Brainstorm Cell Therapeutics' management team discusses an ongoing ALS Phase 3 clinical trial, the company's technology and more.
January 7, 2019
The Biotech Showcase takes place in San Francisco from January 7 to 9. Here's what went on during the conference...
December 17, 2018
BrainStorm Cell Therapeutics (NASDAQ:BCLI), a leading developer of innovative autologous adult stem cell therapeutics for debilitating neurodegenerative diseases, announced that the...
December 10, 2018
The Investing News Network recaps 2018 with the five top biotech news stories of the year, according to our readers.